One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/22192068
Conclusion of this study
Myo-inositol might be considered one of the insulin-sensitizing substances in the treatment of metabolic syndrome.
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
||
|
||
|
||
|
||
|
Body systems related to this study
 Cardiovascular System |
 Digestive System |
 Endocrine System |
